Literature DB >> 16425346

Immunological treatment of liver tumors.

Maurizio Chiriva-Internati1, Fabio Grizzi, Cynthia A Jumper, Everardo Cobos, Paul L Hermonat, Eldo E Frezza.   

Abstract

Although multiple options for the treatment of liver tumors have often been described in the past, including liver resection, radiofrequency ablation with or without hepatic pump insertion, laparoscopic liver resection and the use of chemotherapy, the potential of immunotherapy and gene manipulation is still largely unexplored. Immunological therapy by gene manipulation is based on the interaction between virus-based gene delivery systems and dendritic cells. Using viruses as vectors, it is possible to transduce dendritic cells with genes encoding tumor-associated antigens, thus inducing strong humoral and cellular immunity against the antigens themselves. Both chemotherapy and radiation therapy have the disadvantage of destroying healthy cells, thus causing severe side-effects. We need more precisely targeted therapies capable of killing cancer cells while sparing healthy cells. Our goal is to establish a new treatment for solid liver tumors based on the concept of cytoreduction, and propose an innovative algorithm.

Entities:  

Mesh:

Year:  2005        PMID: 16425346      PMCID: PMC4355746          DOI: 10.3748/wjg.v11.i42.6571

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction.

Authors:  G Fisher-Adams; K K Wong; G Podsakoff; S J Forman; S Chatterjee
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity.

Authors:  P Szabolcs; H F Gallardo; D H Ciocon; M Sadelain; J W Young
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

3.  Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells.

Authors:  Maurizio Chiriva-Internati; Yong Liu; Emanuela Salati; Weiping Zhou; Zhiqing Wang; Fabio Grizzi; Juan J Roman; Seah H Lim; Paul L Hermonat
Journal:  Eur J Immunol       Date:  2002-01       Impact factor: 5.532

Review 4.  Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Hepatic resection for hepatocellular carcinoma.

Authors:  T Tsuzuki; A Sugioka; M Ueda; S Iida; T Kanai; H Yoshii; K Nakayasu
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

6.  Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.

Authors:  C Meyer zum Büschenfelde; N Nicklisch; S Rose-John; C Peschel; H Bernhard
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

Review 7.  Parvovirus vectors for cancer gene therapy.

Authors:  Selvarangan Ponnazhagan
Journal:  Expert Opin Biol Ther       Date:  2004-01       Impact factor: 4.388

Review 8.  Overview of adeno-associated viral vectors.

Authors:  Thomas M Daly
Journal:  Methods Mol Biol       Date:  2004

9.  Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.

Authors:  Nancy L Haigwood; David C Montefiori; William F Sutton; Janela McClure; Andrew J Watson; Gerald Voss; Vanessa M Hirsch; Barbra A Richardson; Norman L Letvin; Shiu-Lok Hu; Philip R Johnson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Biological treatment for liver tumor and new potential biomarkers.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Mitchell S Wachtel; Marjorie Jenkins; Raffaele Ferrari; Everardo Cobos; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.